Eosinopenia as a predictor of unexpected re-admission and mortality after intensive care unit discharge

Anaesthesia and Intensive Care

Volumn 41, Issue 2, 2013, Pages 231-241

  Yip, C B ^a,b   Ho, K M ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Department of Anaesthesia ^*  (Australia)

Author keywords

Infection; Quality indicators; Re admission; Sensitivity and specificity; Survival

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ADVERSE OUTCOME; AGED; APACHE; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTIVE SURGERY; EOSINOPENIA; EOSINOPHIL COUNT; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORTALITY; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; VENOUS THROMBOEMBOLISM;

EID: 84876800063     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1304100130     Document Type: Article

References (33)

1. Ho KM, Dobb GJ, Lee KY, Towler SC, Webb SA. C-reactive protein concentration as a predictor of intensive care unit readmission: a nested case-control study. J Crit Care 2006; 21: 259-265. (Pubitemid 44380341)
2. Rosenberg AL, Hofer TP, Hayward RA, Strachan C, Watts CM. Who bounces back? Physiologic and other predictors of intensive care unit readmission. Crit Care Med 2001; 29: 511-518. (Pubitemid 32225291)
3. Azoulay E, Alberti C, Legendre I, Buisson CB, Le Gall JR, European Sepsis Group. Post-ICU mortality in critically ill infected patients: an international study. Intensive Care Med 2005; 31: 56-63. (Pubitemid 40174282)
4. Ho KM, Lee KY, Dobb GJ, Webb SA. C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: a prospective cohort study. Intensive Care Med 2008; 34: 481-487. (Pubitemid 351623026)
5. Rosenberg AL, Watts C. Patients readmitted to ICUs: a systematic review of risk factors and outcomes. Chest 2000; 118: 492-502. (Pubitemid 30637821)
6. Wallis CB, Davies HT, Shearer AJ. Why do patients die on general wards after discharge from intensive care units? Anaesthesia 1997; 52: 9-14. (Pubitemid 27035853)
7. Ho KM, Burrell M, Rao S, Baker R. Incidence and risk factors for fatal pulmonary embolism after major trauma: a nested cohort study. Br J Anaesth 2010; 105: 596-602.
8. Ho KM, Dobb GJ, Lee KY, Finn J, Knuiman M, Webb SA. The effect of comorbidities on risk of intensive care readmission during the same hospitalization: a linked data cohort study. J Crit Care 2009; 24: 101-107.
9. Pilcher DV, Duke GJ, George C, Bailey MJ, Hart G. Afterhours discharge from intensive care increases the risk of readmission and death. Anaesth Intensive Care 2007; 35: 477-485. (Pubitemid 47322309)
10. Beck DH, McQuillan P, Smith GB. Waiting for the break of dawn? The effects of discharge time, discharge TISS scores and discharge facility on hospital mortality after intensive care. Intensive Care Med 2002; 28: 1287-1293. (Pubitemid 35025048)
11. Grander W, Dünser M, Stollenwerk B, Siebert U, Dengg C, Koller B et al. C-reactive protein levels and post-ICU mortality in nonsurgical intensive care patients. Chest 2010; 138: 856-862.
12. Daly K, Beale R, Chang RW. Reduction in mortality after inappropriate early discharge from intensive care unit: logistic regression triage model. BMJ 2001; 322: 1274-1276. (Pubitemid 32493960)
13. Smith L, Orts CM, O'Neil I, Batchelor AM, Gascoigne AD, Baudouin SV. TISS and mortality after discharge from intensive care. Intensive Care Med 1999; 25: 1061-1065. (Pubitemid 29525059)
14. O uanes I, Schwebel C, Français A, Bruel C, Philippart F, Vesin A et al. A model to predict short-term death or readmission after intensive care unit discharge. J Crit Care 2012; 27:422.e1-9.
15. Bass DA, Gonwa TA, Szejda P, Cousart MS, DeChatelet LR, McCall CE. Eosinopenia of acute infection: Production of eosinopenia by chemotactic factors of acute inflammation. J Clin Invest 1980; 65: 1265-1271. (Pubitemid 10122367)
16. Gil H, Magy N, Mauny F, Dupond JL. Value of eosinopenia in inflammatory disorders: an "old" marker revisited. Rev Med Interne 2003; 24: 431-435. (Pubitemid 36781705)
17. Abidi K, Belayachi J, Derras Y, Khayari ME, Dendane T, Madani N et al. Eosinopenia, an early marker of increased mortality in critically ill medical patients. Intensive Care Med 2011; 37: 1136-1142.
18. Wibrow BA, Ho KM, Flexman JP, Keil AD, Kohrs DL. Eosinopenia as a diagnostic marker of bloodstream infection in hospitalised paediatric and adult patients: a case-control study. Anaesth Intensive Care 2011; 39: 224-230.
19. Abidi K, Khoudri I, Belayachi J, Madani N, Zekraoui A, Zeggwagh AA et al. Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units. Crit Care 2008; 12:R59.
20. Shaaban H, Daniel S, Sison R, Slim J, Perez G. Eosinopenia: Is it a good marker of sepsis in comparison to procalcitonin and C-reactive protein levels for patients admitted to a critical care unit in an urban hospital? J Crit Care 2010; 25: 570-575.
21. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707-710.
22. Ho KM. Combining sequential organ failure assessment (SOFA) score with acute physiology and chronic health evaluation (APACHE) II score to predict hospital mortality of critically ill patients. Anaesth Intensive Care 2007; 35: 515-521. (Pubitemid 47322315)
23. Ho KM, Towler SC. A comparison of eosinopenia and C-reactive protein as a marker of bloodstream infections in critically ill patients: a case control study. Anaesth Intensive Care 2009; 37: 450-456.
24. Tan BT, Nava AJ, George TI. Evaluation of the Beckman Coulter UniCel DxH 800 and Abbott Diagnostics Cell-Dyn Sapphire hematology analyzers on pediatric and neonatal specimens in a tertiary care hospital. Am J Clin Pathol 2011; 135: 929-938.
25. Ho KM, Yip CB, Duff O. Reactive thrombocytosis and risk of subsequent venous thromboembolism: a cohort study. J Thromb Haemost 2012; 10: 1768-1774.
26. Ho KM, Knuiman M, Finn J, Webb SA. Estimating long-term survival of critically ill patients: the PREDICT model. PLoS One 2008; 3:e3226.
27. Kaben A, Corrêa F, Reinhart K, Settmacher U, Gummert J, Kalff R et al. Readmission to a surgical intensive care unit: incidence, outcome and risk factors. Crit Care 2008; 12:R123.
28. Araújo I, Gonçalves-Pereira J, Teixeira S, Nazareth R, Silvestre J, Mendes V et al. Assessment of risk factors for in-hospital mortality after intensive care unit discharge. Biomarkers 2012; 17: 180-185.
29. Silvestre J, Coelho L, Póvoa P. Should C-reactive protein concentration at ICU discharge be used as a prognostic marker? BMC Anesthesiol 2010; 10:17.
30. Al-Subaie N, Reynolds T, Myers A, Sunderland R, Rhodes A, Grounds RM et al. C-reactive protein as a predictor of outcome after discharge from the intensive care: a prospective observational study. Br J Anaesth 2010; 105: 318-325.
31. Bass DA. Behavior of eosinophil leukocytes in acute inflammation. II. Eosinophil dynamics during acute inflammation. J Clin Invest 1975; 56: 870-879.
32. Ho KM, Lipman J. An update on C-reactive protein for intensivists. Anaesth Intensive Care 2009; 37: 234-241.
33. Ho KM. Ten commandments of interpreting and applying results of biomarker research. Anaesth Intensive Care 2011; 39: 799-801.